KFH-Bahrain has increased its holding of AstronClinica to 47% from 9% in 2006. AstronClinica is poised to play a critical role in the skin care technology with Spectrophotometric Intracutaneous Analysis or SIAscopy, a revolutionary approach to skin imaging. Through continuous product development, the Company is opening up a wide range of diagnostic and treatment procedures for skin cancer and other skin conditions.
The Company is based in Cambridge, UK, with a wholly-owned subsidiary in Australia, and several distributors across Canada, Europe, Middle East, Australia and New Zealand. To enable the general public to get a basic understanding of the technology, AstronClinica, in partnership with Procter & Gamble, placed SIAscope skin imaging devices at Olay counters in various countries. This is considered to be a significant milestone for the company.
AstronClinica was recently recognized with the prestigious Frost & Sullivan European Technology Innovation of the Year Award for pioneering efforts in developing a healthcare technology product.
For more information visit www.astronclinica.com